Medicare, Medicaid, and Children's Health Insurance Programs; Provider Enrollment Application Fee Amount for Calendar Year 2023, 74422-74424 [2022-26340]
Download as PDF
74422
Federal Register / Vol. 87, No. 232 / Monday, December 5, 2022 / Notices
PREVIOUSLY ANNOUNCED TIME, DATE, AND
PLACE OF THE MEETING: Thursday,
decision of the Commission shall be
issued by June 12, 2024.
December 1, 2022 at 10:00 a.m.
Hybrid Meeting: 1050 First Street NE,
Washington, DC (12th floor) and Virtual.
William Cody,
Secretary.
The Open
Meeting began at 10:30 a.m.
The following matters were also
considered:
CHANGES IN THE MEETING:
[FR Doc. 2022–26315 Filed 12–2–22; 8:45 am]
BILLING CODE 6730–02–P
REG 2013–01 (Technological
Modernization): Supplemental Notice
of Proposed Rulemaking
Draft Advisory Opinion 2022–24: Allen
Blue
CONTACT PERSON FOR MORE INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
(Authority: Government in the Sunshine Act,
5 U.S.C. 552b)
Vicktoria J. Allen,
Acting Deputy Secretary of the Commission.
[FR Doc. 2022–26498 Filed 12–1–22; 4:15 pm]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–6092–N]
RIN 0938–ZB73
Medicare, Medicaid, and Children’s
Health Insurance Programs; Provider
Enrollment Application Fee Amount for
Calendar Year 2023
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
BILLING CODE 6715–01–P
This notice announces a
$688.00 calendar year (CY) 2023
application fee for institutional
providers that are initially enrolling in
the Medicare or Medicaid program or
the Children’s Health Insurance
Program (CHIP); revalidating their
Medicare, Medicaid, or CHIP
enrollment; or adding a new Medicare
practice location. This fee is required
with any enrollment application
submitted on or after January 1, 2023
and on or before December 31, 2023.
DATES: The application fee announced
in this notice is effective on January 1,
2023.
FOR FURTHER INFORMATION CONTACT:
Frank Whelan, (410) 786–1302.
SUPPLEMENTARY INFORMATION:
SUMMARY:
FEDERAL MARITIME COMMISSION
[Docket No. 22–31]
Thompson Pipe Group, Inc.
Complainant v. Omni Logistics LLC,
Respondent; Notice of Filing of
Complaint and Assignment
ddrumheller on DSK30NT082PROD with NOTICES
Served: November 29, 2022.
Notice is given that a complaint has
been filed with the Federal Maritime
Commission (Commission) by
Thompson Pipe Group, Inc. hereinafter
‘‘Complainant,’’ against Omni Logistics
LLC (f/k/a Epic Freight Service),
hereinafter ‘‘Respondent.’’ Complainant
states that it is a corporation organized
in the State of Texas. Complainant
identifies the Respondent as a limited
liability company organized under the
laws of the State of Texas and a NonVessel-Operating Common Carrier.
Complainant alleges that Respondent
violated 46 U.S.C. 41102(c),41102(d),
and 41104(a) in its practices, and
assessment of charges, including
demurrage and other non-freight
charges, related to the movement of
containers. The full text of the
complaint can be found in the
Commission’s Electronic Reading Room
at https://www2.fmc.gov/readingroom/
proceeding/22-31/.
This proceeding has been assigned to
Office of Administrative Law Judges.
The initial decision of the presiding
officer in this proceeding shall be issued
by November 29, 2023, and the final
VerDate Sep<11>2014
19:34 Dec 02, 2022
Jkt 259001
I. Background
In the February 2, 2011 Federal
Register (76 FR 5862), we published a
final rule with comment period titled
‘‘Medicare, Medicaid, and Children’s
Health Insurance Programs; Additional
Screening Requirements, Application
Fees, Temporary Enrollment Moratoria,
Payment Suspensions and Compliance
Plans for Providers and Suppliers.’’ This
rule finalized, among other things,
provisions related to the submission of
application fees as part of the Medicare,
Medicaid, and CHIP provider
enrollment processes. As provided in
section 1866(j)(2)(C)(i) of the Social
Security Act (the Act) and in 42 CFR
424.514, ‘‘institutional providers’’ that
are initially enrolling in the Medicare or
Medicaid programs or CHIP,
revalidating their enrollment, or adding
a new Medicare practice location are
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
required to submit a fee with their
enrollment application. An
‘‘institutional provider’’ for purposes of
Medicare is defined at § 424.502 as ‘‘any
provider or supplier that submits a
paper Medicare enrollment application
using the CMS–855A, CMS–855B (not
including physician and non-physician
practitioner organizations), CMS–855S,
or associated internet-based PECOS
enrollment application.’’ As we
explained in the February 2, 2011 final
rule (76 FR 5914), in addition to the
providers and suppliers subject to the
application fee under Medicare,
Medicaid-only and CHIP-only
institutional providers would include
nursing facilities, intermediate care
facilities for persons with intellectual
disabilities (ICF/IID), and psychiatric
residential treatment facilities; they may
also include other institutional provider
types designated by a state in
accordance with their approved state
plan.
As indicated in § 424.514 and
§ 455.460, the application fee is not
required for either of the following:
• A Medicare physician or nonphysician practitioner submitting a
CMS–855I.
• A prospective or revalidating
Medicaid or CHIP provider—
++ Who is an individual physician or
non-physician practitioner; or
++ That is enrolled as an institutional
provider in Title XVIII of the Act or
another state’s Title XIX or XXI plan
and has paid the application fee to a
Medicare contractor or another state.
II. Provisions of the Notice
Section 1866(j)(2)(C)(i)(I) of the Act
established a $500 application fee for
institutional providers in CY 2010.
Consistent with section
1866(j)(2)(C)(i)(II) of the Act,
§ 424.514(d)(2) states that for CY 2011
and subsequent years, the preceding
year’s fee will be adjusted by the
percentage change in the consumer
price index (CPI) for all urban
consumers (all items; United States city
average, CPI–U) for the 12-month period
ending on June 30 of the previous year.
Consequently, each year since 2011 we
have published in the Federal Register
an announcement of the application fee
amount for the forthcoming CY based on
this formula. Most recently, in the
October 25, 2021 Federal Register (86
FR 58917), we published a notice
announcing a fee amount for the period
of January 1, 2022 through December 31,
2022 of $631.00. The $631.00 fee
amount for CY 2022 was used to
calculate the fee amount for 2023 as
specified in § 424.514(d)(2).
E:\FR\FM\05DEN1.SGM
05DEN1
Federal Register / Vol. 87, No. 232 / Monday, December 5, 2022 / Notices
According to Bureau of Labor
Statistics (BLS) data, the CPI–U increase
for the period of July 1, 2021 through
June 30, 2022 was 9.1 percent. As
required by § 424.514(d)(2), the
preceding year’s fee of $631 will be
adjusted by 9.1 percent. This results in
a CY 2023 application fee amount of
$688.42 ($631 × 1.091). As we must
round this to the nearest whole dollar
amount, the resultant application fee
amount for CY 2023 is $688.00.
III. Collection of Information
Requirements
This document does not impose
information collection requirements
(that is, reporting, recordkeeping, or
third-party disclosure requirements).
Accordingly, there is no need for review
by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995.
However, it does reference previously
approved information collections. The
CMS–855A, CMS–855B, CMS–855I, and
CMS–855S applications are approved
under, respectively, OMB control
numbers 0938–0685, 0938–1377, 0938–
1355, and 0938–1056.
IV. Regulatory Impact Statement
ddrumheller on DSK30NT082PROD with NOTICES
A. Background and Review
Requirements
We have examined the impact of this
notice as required by Executive Order
12866 on Regulatory Planning and
Review (September 30, 1993), Executive
Order 13563 on Improving Regulation
and Regulatory Review (January 18,
2011), the Regulatory Flexibility Act
(RFA) (September 19, 1980, Pub. L. 96–
354), section 1102(b) of the Act, section
202 of the Unfunded Mandates Reform
Act of 1995 (March 22, 1995; Pub. L.
104–4), Executive Order 13132 on
Federalism (August 4, 1999), and the
Congressional Review Act (5 U.S.C.
804(2)).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits,
including potential economic,
environmental, public health and safety
effects, distributive impacts, and equity.
A regulatory impact analysis (RIA) must
be prepared for major rules with
economically significant effects ($100
million or more in any 1 year). As
explained in this section of the notice,
we estimate that the total cost of the
increase in the application fee will not
exceed $100 million. Therefore, this
notice does not reach the $100 million
VerDate Sep<11>2014
19:34 Dec 02, 2022
Jkt 259001
economic threshold and is not
considered a major notice.
B. Costs
The costs associated with this notice
involve the increase in the application
fee amount that certain providers and
suppliers must pay in CY 2023. The CY
2023 cost estimates are as follows:
1. Medicare
Based on CMS data, we estimate that
in CY 2023 approximately—
• 14,726 newly enrolling institutional
providers will be subject to and pay an
application fee; and
• 47,000 revalidating institutional
providers will be subject to and pay an
application fee.
Using a figure of 61,726 (14,726 newly
enrolling + 47,000 revalidating)
institutional providers, we estimate an
increase in the cost of the Medicare
application fee requirement in CY 2023
of $3,518,382 (or 61,726 × $57 (or $688
minus $631)) from our CY 2022
projections.
2. Medicaid and CHIP
Based on CMS and state statistics, we
estimate that approximately 30,000
(9,000 newly enrolling + 21,000
revalidating) Medicaid and CHIP
institutional providers will be subject to
an application fee in CY 2023. Using
this figure, we project an increase in the
cost of the Medicaid and CHIP
application fee requirement in CY 2023
of $1,710,000 (or 30,000 × $57 (or $688
minus $631)) from our CY 2022
projections.
3. Total
Based on the foregoing, we estimate
the total increase in the cost of the
application fee requirement for
Medicare, Medicaid, and CHIP
providers and suppliers in CY 2023 to
be $5,228,382 ($3,518,382 + $1,710,000)
from our CY 2022 projections.
We do not anticipate any negative
impact on equity from the increase in
the application fee amount, which we
calculated in accordance with the
requirements specified in statute and
regulation. Prior application fee
increases have had no such discernable
effect, and we reiterate that the fee
requirement does not apply to
individual physicians and nonphysician practitioners completing the
CMS–855I, who represent the
overwhelming preponderance of the
more than 2 million Medicare-enrolled
providers and suppliers.
The RFA requires agencies to analyze
options for regulatory relief of small
businesses. For purposes of the RFA,
small entities include small businesses,
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
74423
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
nonprofit status or by having revenues
of less than $8 million to $41.5 million
in any 1 year. Individuals and states are
not included in the definition of a small
entity. As we stated in the RIA for the
February 2, 2011 final rule (76 FR 5952),
we do not believe that the application
fee will have a significant impact on
small entities.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a Metropolitan Statistical Area for
Medicare payment regulations and has
fewer than 100 beds. We are not
preparing an analysis for section 1102(b)
of the Act because we have determined,
and the Secretary certifies, that this
notice would not have a significant
impact on the operations of a substantial
number of small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
also requires that agencies assess
anticipated costs and benefits before
issuing any rule whose mandates
require spending in any 1 year of $100
million in 1995 dollars, updated
annually for inflation. In 2022, that
threshold was approximately $165
million. The Agency has determined
that there will be minimal impact from
the costs of this notice, as the threshold
is not met under the UMRA.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it promulgates a
proposed rule (and subsequent final
rule) that imposes substantial direct
requirement costs on state and local
governments, preempts state law, or
otherwise has federalism implications.
Since this notice does not impose
substantial direct costs on state or local
governments, the requirements of
Executive Order 13132 are not
applicable.
In accordance with the provisions of
Executive Order 12866, this notice was
reviewed by the Office of Management
and Budget.
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Lynette Wilson, who is the
Federal Register Liaison, to
electronically sign this document.
E:\FR\FM\05DEN1.SGM
05DEN1
74424
Federal Register / Vol. 87, No. 232 / Monday, December 5, 2022 / Notices
Dated: November 29, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2022–26340 Filed 12–2–22; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget (OMB) Review; Procedural
Justice-Informed Alternatives to
Contempt Demonstration (OMB #0970–
0505)
Office of Child Support
Enforcement, Administration for
Children and Families, Department of
Health and Human Services.
ACTION: Request for public comments.
AGENCY:
The Office of Child Support
Enforcement (OCSE), Administration for
Children and Families (ACF), U.S.
Department of Health and Human
Services (HHS), is proposing to add
additional data collection activities as
part of the rigorous evaluation of the
Procedural Justice-Informed
Alternatives to Contempt (PJAC)
Demonstration. The proposed revision
to conduct additional data collection is
part of a research supplement that
builds on the PJAC study to understand
the role of bias in child support program
enforcement actions.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
SUMMARY:
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing infocollection@
acf.hhs.gov. Identify all emailed
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: OCSE is proposing to
conduct additional data collection
activities as part of the PJAC
Demonstration. In September 2016,
OCSE issued grants to five state child
support agencies to provide alternative
approaches to the contempt process
with the goal of increasing noncustodial
parents’ compliance with child support
orders by building trust and confidence
in the child support agency and its
processes. OCSE also awarded a grant to
support a rigorous evaluation of PJAC.
The PJAC Demonstration is designed to
help grantees and OCSE to learn
whether incorporating principles of
procedural justice into child support
business practices increases reliable
child support payments, reduces
arrears, minimizes the need for
continued enforcement actions and
sanctions, and reduces the use of
contempt proceedings.
The PJAC demonstration will yield
information about the efficacy of
applying procedural justice principles
via a set of alternative services to the
current use of a civil contempt process
to address nonpayment of child support.
As a part of the evaluation, PJAC will
build evidence about disparity and bias
in the child support system, with a
focus on the use of enforcement actions
used to coerce child support payments.
The research will measure the extent to
which bias is embedded within child
support policies and practices. The
information gathered may help inform
future policy decisions to better
understand and reduce disparities
within the child support program.
The research will document
disparities and differences in treatment
by race and ethnicity, gender, and
income within the child support system
in up to three states participating in the
PJAC demonstration. Key elements of
the study include a quantitative analysis
of disparities in the initiation of a child
support case, setting of order amounts,
order modifications, and use of punitive
enforcement actions, including civil
contempt; semi-structured interviews
with staff from child support agencies
and selected partner organizations; and
separate semi-structured interviews
with study participants to learn about
their experiences with and perceptions
of bias in the child support process,
specifically in the use of enforcement
actions.
OCSE is proposing to conduct
additional data collection activities as
part of the PJAC Demonstration, which
include the following: a topic guide for
interviews about experiences of bias
with noncustodial parents and a topic
guide for interviews about experiences
of bias with child support staff and
partners.
Data collection activities that were
previously approved by OMB, following
public comment, are the staff data entry
on participant baseline information,
study Management Information Systems
(MIS) to track receipt of services, staff
and community partner interview topic
guide, the noncustodial parent
participant interview protocol, the staff
survey, the staff time study, and the
custodial parent interview protocol.
These instruments are currently in use
and this request will extend approval to
continue data collection. Supporting
materials, including burden estimates
related to approved instruments are
available at https://www.reginfo.gov/
public/do/PRAICList?ref_nbr=2022020970-013. The following burden table
includes information for the proposed
new interviews.
Respondents: Respondents for the
new data collection instruments include
study participants and child support
program staff and partners at three of
the six PJAC demonstration sites.
ANNUAL BURDEN ESTIMATES
Total
number of
respondents
ddrumheller on DSK30NT082PROD with NOTICES
Instrument
Topic list for interviews about experiences of bias with
staff and partners .............................................................
Topic guide for interviews about experiences of bias with
noncustodial parents ........................................................
VerDate Sep<11>2014
19:34 Dec 02, 2022
Jkt 259001
PO 00000
Frm 00034
Fmt 4703
Total
number of
responses per
respondent
Average
burden hours
per response
Total
burden hours
Annual
burden hours
90
1
1.5
135
45
90
1
1
90
30
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
Agencies
[Federal Register Volume 87, Number 232 (Monday, December 5, 2022)]
[Notices]
[Pages 74422-74424]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-26340]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-6092-N]
RIN 0938-ZB73
Medicare, Medicaid, and Children's Health Insurance Programs;
Provider Enrollment Application Fee Amount for Calendar Year 2023
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces a $688.00 calendar year (CY) 2023
application fee for institutional providers that are initially
enrolling in the Medicare or Medicaid program or the Children's Health
Insurance Program (CHIP); revalidating their Medicare, Medicaid, or
CHIP enrollment; or adding a new Medicare practice location. This fee
is required with any enrollment application submitted on or after
January 1, 2023 and on or before December 31, 2023.
DATES: The application fee announced in this notice is effective on
January 1, 2023.
FOR FURTHER INFORMATION CONTACT: Frank Whelan, (410) 786-1302.
SUPPLEMENTARY INFORMATION:
I. Background
In the February 2, 2011 Federal Register (76 FR 5862), we published
a final rule with comment period titled ``Medicare, Medicaid, and
Children's Health Insurance Programs; Additional Screening
Requirements, Application Fees, Temporary Enrollment Moratoria, Payment
Suspensions and Compliance Plans for Providers and Suppliers.'' This
rule finalized, among other things, provisions related to the
submission of application fees as part of the Medicare, Medicaid, and
CHIP provider enrollment processes. As provided in section
1866(j)(2)(C)(i) of the Social Security Act (the Act) and in 42 CFR
424.514, ``institutional providers'' that are initially enrolling in
the Medicare or Medicaid programs or CHIP, revalidating their
enrollment, or adding a new Medicare practice location are required to
submit a fee with their enrollment application. An ``institutional
provider'' for purposes of Medicare is defined at Sec. 424.502 as
``any provider or supplier that submits a paper Medicare enrollment
application using the CMS-855A, CMS-855B (not including physician and
non-physician practitioner organizations), CMS-855S, or associated
internet-based PECOS enrollment application.'' As we explained in the
February 2, 2011 final rule (76 FR 5914), in addition to the providers
and suppliers subject to the application fee under Medicare, Medicaid-
only and CHIP-only institutional providers would include nursing
facilities, intermediate care facilities for persons with intellectual
disabilities (ICF/IID), and psychiatric residential treatment
facilities; they may also include other institutional provider types
designated by a state in accordance with their approved state plan.
As indicated in Sec. 424.514 and Sec. 455.460, the application
fee is not required for either of the following:
A Medicare physician or non-physician practitioner
submitting a CMS-855I.
A prospective or revalidating Medicaid or CHIP provider--
++ Who is an individual physician or non-physician practitioner; or
++ That is enrolled as an institutional provider in Title XVIII of
the Act or another state's Title XIX or XXI plan and has paid the
application fee to a Medicare contractor or another state.
II. Provisions of the Notice
Section 1866(j)(2)(C)(i)(I) of the Act established a $500
application fee for institutional providers in CY 2010. Consistent with
section 1866(j)(2)(C)(i)(II) of the Act, Sec. 424.514(d)(2) states
that for CY 2011 and subsequent years, the preceding year's fee will be
adjusted by the percentage change in the consumer price index (CPI) for
all urban consumers (all items; United States city average, CPI-U) for
the 12-month period ending on June 30 of the previous year.
Consequently, each year since 2011 we have published in the Federal
Register an announcement of the application fee amount for the
forthcoming CY based on this formula. Most recently, in the October 25,
2021 Federal Register (86 FR 58917), we published a notice announcing a
fee amount for the period of January 1, 2022 through December 31, 2022
of $631.00. The $631.00 fee amount for CY 2022 was used to calculate
the fee amount for 2023 as specified in Sec. 424.514(d)(2).
[[Page 74423]]
According to Bureau of Labor Statistics (BLS) data, the CPI-U
increase for the period of July 1, 2021 through June 30, 2022 was 9.1
percent. As required by Sec. 424.514(d)(2), the preceding year's fee
of $631 will be adjusted by 9.1 percent. This results in a CY 2023
application fee amount of $688.42 ($631 x 1.091). As we must round this
to the nearest whole dollar amount, the resultant application fee
amount for CY 2023 is $688.00.
III. Collection of Information Requirements
This document does not impose information collection requirements
(that is, reporting, recordkeeping, or third-party disclosure
requirements). Accordingly, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995. However, it does reference previously approved information
collections. The CMS-855A, CMS-855B, CMS-855I, and CMS-855S
applications are approved under, respectively, OMB control numbers
0938-0685, 0938-1377, 0938-1355, and 0938-1056.
IV. Regulatory Impact Statement
A. Background and Review Requirements
We have examined the impact of this notice as required by Executive
Order 12866 on Regulatory Planning and Review (September 30, 1993),
Executive Order 13563 on Improving Regulation and Regulatory Review
(January 18, 2011), the Regulatory Flexibility Act (RFA) (September 19,
1980, Pub. L. 96-354), section 1102(b) of the Act, section 202 of the
Unfunded Mandates Reform Act of 1995 (March 22, 1995; Pub. L. 104-4),
Executive Order 13132 on Federalism (August 4, 1999), and the
Congressional Review Act (5 U.S.C. 804(2)).
Executive Orders 12866 and 13563 direct agencies to assess all
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits, including potential economic, environmental, public
health and safety effects, distributive impacts, and equity. A
regulatory impact analysis (RIA) must be prepared for major rules with
economically significant effects ($100 million or more in any 1 year).
As explained in this section of the notice, we estimate that the total
cost of the increase in the application fee will not exceed $100
million. Therefore, this notice does not reach the $100 million
economic threshold and is not considered a major notice.
B. Costs
The costs associated with this notice involve the increase in the
application fee amount that certain providers and suppliers must pay in
CY 2023. The CY 2023 cost estimates are as follows:
1. Medicare
Based on CMS data, we estimate that in CY 2023 approximately--
14,726 newly enrolling institutional providers will be
subject to and pay an application fee; and
47,000 revalidating institutional providers will be
subject to and pay an application fee.
Using a figure of 61,726 (14,726 newly enrolling + 47,000
revalidating) institutional providers, we estimate an increase in the
cost of the Medicare application fee requirement in CY 2023 of
$3,518,382 (or 61,726 x $57 (or $688 minus $631)) from our CY 2022
projections.
2. Medicaid and CHIP
Based on CMS and state statistics, we estimate that approximately
30,000 (9,000 newly enrolling + 21,000 revalidating) Medicaid and CHIP
institutional providers will be subject to an application fee in CY
2023. Using this figure, we project an increase in the cost of the
Medicaid and CHIP application fee requirement in CY 2023 of $1,710,000
(or 30,000 x $57 (or $688 minus $631)) from our CY 2022 projections.
3. Total
Based on the foregoing, we estimate the total increase in the cost
of the application fee requirement for Medicare, Medicaid, and CHIP
providers and suppliers in CY 2023 to be $5,228,382 ($3,518,382 +
$1,710,000) from our CY 2022 projections.
We do not anticipate any negative impact on equity from the
increase in the application fee amount, which we calculated in
accordance with the requirements specified in statute and regulation.
Prior application fee increases have had no such discernable effect,
and we reiterate that the fee requirement does not apply to individual
physicians and non-physician practitioners completing the CMS-855I, who
represent the overwhelming preponderance of the more than 2 million
Medicare-enrolled providers and suppliers.
The RFA requires agencies to analyze options for regulatory relief
of small businesses. For purposes of the RFA, small entities include
small businesses, nonprofit organizations, and small governmental
jurisdictions. Most hospitals and most other providers and suppliers
are small entities, either by nonprofit status or by having revenues of
less than $8 million to $41.5 million in any 1 year. Individuals and
states are not included in the definition of a small entity. As we
stated in the RIA for the February 2, 2011 final rule (76 FR 5952), we
do not believe that the application fee will have a significant impact
on small entities.
In addition, section 1102(b) of the Act requires us to prepare a
regulatory impact analysis if a rule may have a significant impact on
the operations of a substantial number of small rural hospitals. This
analysis must conform to the provisions of section 604 of the RFA. For
purposes of section 1102(b) of the Act, we define a small rural
hospital as a hospital that is located outside of a Metropolitan
Statistical Area for Medicare payment regulations and has fewer than
100 beds. We are not preparing an analysis for section 1102(b) of the
Act because we have determined, and the Secretary certifies, that this
notice would not have a significant impact on the operations of a
substantial number of small rural hospitals.
Section 202 of the Unfunded Mandates Reform Act of 1995 (UMRA) also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any 1 year of $100
million in 1995 dollars, updated annually for inflation. In 2022, that
threshold was approximately $165 million. The Agency has determined
that there will be minimal impact from the costs of this notice, as the
threshold is not met under the UMRA.
Executive Order 13132 establishes certain requirements that an
agency must meet when it promulgates a proposed rule (and subsequent
final rule) that imposes substantial direct requirement costs on state
and local governments, preempts state law, or otherwise has federalism
implications. Since this notice does not impose substantial direct
costs on state or local governments, the requirements of Executive
Order 13132 are not applicable.
In accordance with the provisions of Executive Order 12866, this
notice was reviewed by the Office of Management and Budget.
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Lynette Wilson, who is the Federal Register
Liaison, to electronically sign this document.
[[Page 74424]]
Dated: November 29, 2022.
Lynette Wilson,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2022-26340 Filed 12-2-22; 8:45 am]
BILLING CODE 4120-01-P